5zqu: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "5zqu" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 5zqu is ON HOLD | The entry 5zqu is ON HOLD until Paper Publication | ||
Authors: Miyashita, Y., Numoto, N., Arulmozhiraja, S., Nakano, S., Matsuo, N., Shimizu, K., Kakuta, H., Ito, S., Ikura, T., Ito, N., Tokiwa, H. | Authors: Miyashita, Y., Numoto, N., Arulmozhiraja, S., Nakano, S., Matsuo, N., Shimizu, K., Kakuta, H., Ito, S., Ikura, T., Ito, N., Tokiwa, H. | ||
| Line 16: | Line 16: | ||
[[Category: Tokiwa, H]] | [[Category: Tokiwa, H]] | ||
[[Category: Miyashita, Y]] | [[Category: Miyashita, Y]] | ||
[[Category: Matsuo, N]] | |||
[[Category: Kakuta, H]] | [[Category: Kakuta, H]] | ||
Revision as of 07:04, 13 February 2019
Unreleased structure
The entry 5zqu is ON HOLD until Paper Publication
Authors: Miyashita, Y., Numoto, N., Arulmozhiraja, S., Nakano, S., Matsuo, N., Shimizu, K., Kakuta, H., Ito, S., Ikura, T., Ito, N., Tokiwa, H.
Description: Crystal structure of tetrameric RXRalpha-LBD complexed with partial agonist CBt-PMN